Literature DB >> 282093

Are racial differences in essential hypertension due to different pathogenetic mechanisms?

P S Sever, W S Peart, T W Meade, I B Davies, D Gordon, R D Tunbridge.   

Abstract

1. Plasma noradrenaline concentration and plasma renin activity were measured in a control, British, urban population (n = 115) in which blacks were matched for age and sex with whites. 2. Similar measurements were made in subjects with essential hypertension (77 white and 23 black), and 48 healthy normotensive white civil servants. 3. In controls blood pressure was significantly higher in blacks; it correlated with age in both races and with pulse rate in blacks. There were no significant racial differences in plasma noradrenaline which was positively correlated with age in both blacks and whites. Mean plasma renin activity was 55% lower in blacks, and this difference was not related to urinary sodium excretion. 4. In hypertensive subjects plasma noradrenaline positively correlated with age in blacks. This relationship was not found in whites in whom 20% of young hypertensive subjects (less than 45 years) had significantly raised plasma noradrenaline. Plasma renin activity was again significantly lower in blacks. In white hypertensives plasma noradrenaline and renin activity were significantly correlated. 5. There may be racial differences in the pathogenesis of essential hypertension.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 282093     DOI: 10.1042/cs055383s

Source DB:  PubMed          Journal:  Clin Sci Mol Med Suppl        ISSN: 0144-4107


  2 in total

1.  Sympathetic reflex responses during treatment of essential hypertension with hydrallazine and oxprenolol.

Authors:  I B Davies; P S Sever; T Rosenthal
Journal:  Br J Clin Pharmacol       Date:  1979-07       Impact factor: 4.335

2.  Blood pressure in black, white and Asian factory workers in Birmingham.

Authors:  J K Cruickshank; S H Jackson; L T Bannan; D G Beevers; M Beevers; V L Osbourne
Journal:  Postgrad Med J       Date:  1983-10       Impact factor: 2.401

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.